This observation is of interest because YXXM can bind SH2 domain‐containing molecules that participate in multiple biological processes, including in cancer[61, 62] and immune cells.[63, 64] Comprehensive evaluation of CD96 and its downstream signaling may reveal potential therapeutic benefits. Here, CD96 is linked to cancer.